COURSE DESCRIPTION

The SIOG Advanced Course in Geriatric Oncology focuses on a multi-disciplinary training of experts for the treatment of older cancer patients. In an effort to stimulate learning and interaction, the course covers general principles of cancer treatment using online case-based discussions and debates.

Delegates will benefit from a course format that encourages student-faculty interactions. The lectures will cover themes in geriatrics for clinical oncologists as well as in clinical oncology for geriatricians, including modules on direct patient care for nurses and allied health professionals.

We strive to enable as many health professionals as possible to benefit from this international exchange in geriatric oncology and offer a variety of options for accessing the content of the lectures.

The course focused on a multi-disciplinary training of experts for the treatment of older cancer patients. In an effort to stimulate learning and interaction, the course covered general principles of cancer treatment using case-based discussions and debates.

The SIOG 2022 Advanced Course in Geriatric Oncology – Virtual from Canberra, Canberra, Australia, 22/01/2022 – 23/01/2022 has been granted 14 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®).

Accreditation Statement
Accreditation by the EACCME® confers the right to place the following statement in all communication materials including the event website, the event programme and the certificate of attendance. The following statements must be used without revision:
“The SIOG 2022 Advanced Course in Geriatric Oncology – Virtual from Canberra, Canberra, Australia, 22/01/2022 – 23/01/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 14 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.”

“Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.”
“Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”

EACCME® credits
Each participant can only receive the number of credits he/she is entitled to according to his/her actual participation at the event once he/she has completed the feedback form. Cf. criteria 9 and 23 of UEMS 2016.20.

Chair: Divyanshu Dua (AU)
Co-Chair: Ravindran Kanesvaran (SG)
Members:
Holly Holmes (US)
Kwok-Leung Cheung (UK)

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas -Respiratory & Autoimmunity, Cardiovascular & Metabolic Disease and Oncology. The Company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
For more information, please visit: https://www.astrazeneca.com.au/

Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science.
https://www.bms.com/au
https://twitter.com/bmsnews
https://www.linkedin.com/company/bristol-myers-squibb/
https://www.instagram.com/bristolmyerssquibb/
https://www.facebook.com/BristolMyersSquibb

Ipsen provides specialty medicines and quality services to healthcare professionals and their patients suffering from debilitating diseases.
At Ipsen, our passion is improving the lives of patients. We do this by working together to build partnerships based on trust and mutual respect with Healthcare Professionals. We deliver tailored solutions through our agility and innovation and we strive to be even better tomorrow than we are today.
Ipsen Pty Ltd is the Australian affiliate of a global biotech company.
Please see the website below for details of Ipsen’s presence in Australia: https://www.ipsen.com/aus/

One way or another, cancer touches all our lives. Which is why nothing is more personal, or more urgent, than our goal to find cures for cancer. This motivates all of us at Pfizer, and we share that goal with healthcare providers, patient advocates, caregivers, biopharma companies, and everyone living with cancer.
Together, we’ve made meaningful progress, but our work is far from finished. The millions of people living with cancer and the millions more who will receive a diagnosis are the reason we continue to work relentlessly to deliver on our purpose: breakthroughs that change patients’ lives.
If you would like to submit a medical enquiry regarding a Pfizer product, please visit www.pfizermedicalinformation.com.au
If you need to report an adverse event for a Pfizer medicine, please contact Pfizer Drug Safety at AUS.AEReporting@pfizer.com
Pfizer Australia Pty Limited, Sydney, Australia. www.pfizer.com.au. Medical Information 1800 675 229 PP-PFO-AUS-0034 January 2022.
https://www.pfizer.com.au/
https://www.instagram.com/pfizeraustralia/

The Medical Oncology Group of Australia Incorporated (MOGA) is the national, professional organisation for medical oncologists and the profession in Australia. As a Specialty Society of the Royal Australasian College of Physicians, MOGA maintains strong strategic alliances, working in close collaboration with many professional organisations and agencies in Australia and overseas. We work closely with Government, health organisations, affiliated international associations and societies, industry and learned Colleges to improve and develop the profession of medical oncology and the management of cancer both nationally and globally. https://www.moga.org.au/